Navigation Links
Amgen Highlights Data to Be Presented at ASCO
Date:5/15/2009

factor receptor (IGF-1R)

Lead Author: McCaffery I

Abstract No. 3545 (Saturday, May 30, 2009, 8:00am-12:00pm)

About Vectibix

Vectibix is indicated as a single agent for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal carcinoma after disease progression on, or following fluoropyrimidine-, oxaliplatin- and irinotecan-containing chemotherapy regimens. The effectiveness of Vectibix as a single agent for the treatment of EGFR-expressing, metastatic colorectal carcinoma is based on progression-free survival. Currently no data demonstrate an improvement in disease-related symptoms or increased survival with Vectibix.

Vectibix Important Product Safety Information

Dermatologic Toxicity: Dermatologic toxicities occurred in 89 percent of patients and were severe (NCI-CTC grade 3 and higher) in 12 percent of patients receiving Vectibix monotherapy. Withhold Vectibix for dermatologic toxicities that are grade 3 or higher or are considered intolerable. If toxicity does not improve to less than or equal to grade 2 within 1 month, permanently discontinue Vectibix. The clinical manifestations included, but were not limited to, dermatitis acneiform, pruritus, erythema, rash, skin exfoliation, paronychia, dry skin, and skin fissures. Subsequent to the development of severe dermatologic toxicities, infectious complications, including sepsis, septic death, and abscesses requiring incisions and drainage were reported.

Infusion Reactions: Severe infusion reactions occurred in approximately 1 percent of patients. Severe infusion reactions included anaphylactic reactions, bronchospasm, and hypotension. Although not reported with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Depending on the severity and
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Amgen to Present at the Deutsche Bank 34th Annual Healthcare Conference
2. Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Amgens First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
4. Amgen Announces Webcast of 2009 First Quarter Financial Results
5. Amgen to Present at the Barclays Capital Global Healthcare Conference
6. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
7. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
8. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
9. Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
10. Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society
11. Quality of life survey highlights need for holistic approach in elderly residential care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... ... intermediate or final products. Automating sample handling makes density measurements more efficient and ... each step of the automated workflow and the advantages compared to manual sample ...
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and ... earned international recognition as a premier center for treatment of and research into ... internal bleeding and stroke. , Cure HHT, previously known as The HHT ...
(Date:9/2/2015)... ... 2015 , ... Ericson is a noted speaker and educator in the field ... of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where she developed ... She serves as a CDI subject matter expert for a variety of HCPro and ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... (COIES) is officially announced today. The two day international investment and business conference ... House Oct 9-11, 2015 in Beijing China. The full-weekend networking conference will feature ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg ... extremity surgical market, announced today that more than 600 successful patient procedures have ... hand. Plus, nearly 70 of these procedures have been on triggering thumbs. ...
Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2
... But they are still just as sensitive as anyone else. Ignoring ... so//. ,Members of the "stronger sex" often expect a ... Many only consult a doctor when it's too late and could ... ,German men have a life expectancy of around 76 years, compared ...
... have long known the molecular mechanisms behind most of the ... part by rhodopsin, a pigment molecule that is extremely sensitive ... signals that can be decoded by the brain into visual ... a one-degree change in temperature has remained a mystery. ...
... the annual Compendium of Health Statistics published by the Office ... by caesarian method. This is costing the NHS twice as ... in 1995, the deliveries by C section have increased to ... women from 1995 to 2006. There is an increase of ...
... at the Conference on Retroviruses and Opportunistic Infections in ... Sunday. ,Health professionals made the present scenario ... ravaging South Africa known here. ,The meeting ... to report the latest scientific news on the spread ...
... Delhi: Nearly half of India's children below the age of three ... to bed hungry every day, says new data.// ,The ... Programme (WFP) say 45.9 percent of Indian children under the age ... weight in relation to their height and age. ,"The ...
... people exposed to toxic gases from the Union Carbide plant ... Bhopal gas tragedy Sunday demanded free treatment of the children ... ,The Bhopal tragedy occurred on the night of ... iso-cyanate (MIC) spewed out of the pesticide plant, in one ...
Cached Medicine News:Health News:Men Not as Tough as They Seem 2Health News:Researchers Discover Key to Body’s Ability to Detect Subtle Temperature Change 2Health News:Researchers Discover Key to Body’s Ability to Detect Subtle Temperature Change 3Health News:XDR-TB: the Latest Global Terror 2Health News:Bhopal Gas Victims Demand Treatment of Children With Birth Defects 2
(Date:9/2/2015)... 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ... Drug Delivery (London, UK - November 19-20, 2015)" ... Delivery meeting will cover industry case studies, regulatory updates, ... Co-Chairmen are Dr Steven Nichols , OINP Specialist ... Companies participating include: ...
(Date:9/2/2015)... Miss. , Sept. 2, 2015   Gulf Coast Tattoo ... removal services with the cutting-edge Astanza Duality laser in ... unwanted ink erase their tattoo regret and take back control of ... but extends its services to Biloxi ... region. "With tattoo regret being as prevalent as it ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ) ... Device Studies: Clinical Evidence (London, UK - November ... This course has been designed specifically ... evidence required for medical devices and in-vitro diagnostic ... devices and the emphasis on high quality, appropriate ...
Breaking Medicine Technology:Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2
... , July 7 /PRNewswire-FirstCall/ ... a biopharmaceutical company focused on the development of novel ... completed the dosing of the last patient in NIL-CDNP-CT005, ... in patients with acute decompensated heart failure, or ADHF. ...
... , LOUISVILLE, Ky. , July 6 ... of Revonto™ (dantrolene sodium for injection), the first patented ...  The time to reconstitute dantrolene sodium for injection has ... the solution is clear.  Revonto™ retains the cost-savings of ...
Cached Medicine Technology:Nile Therapeutics Completes Dosing of Phase II Study 2Nile Therapeutics Completes Dosing of Phase II Study 3US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection) 2
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Tennant curved tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
Medicine Products: